NYMOX PHARMA ANNOUNCES REGULATORY MILESTONE IN EUROPE FOR NICALERT PRODUCT

A A

Friday, Nymox Pharmaceutical Corp. said it received certification in Europe with the CE Mark for its saliva-based version of its NicAlert product for testing for tobacco use. NicAlert Saliva uses Nymox's patented technology to provide an easy-to-use, on-site visual read-out of an individual's level of tobacco use or exposure.

Trading Markets (http://www.tradingmarkets.com/tm.site/news/BREAKING%20NEWS/246560/)